Maker's videoMMI - Medical Microinstruments, Inc. · 3 Feb 2026
The Synaptix™ Digital Surgery Platform: Purpose-Built to Enhance Symani®
Against the record
Symani, from MMI (Medical Microinstruments), is at stage 5 of 5 on our ladder: regulator-cleared or mass market. Cleared where approval applies, or widely sold. The latest milestone on its record is from 4 May 2026: Baptist Health in Jacksonville, Florida did the first operation in a US study (REMIND) testing Symani microsurgery for Alzheimer's and similar brain diseases. The study plans 15 patients.
This video comes from the maker's own channel, and makers show their robots at their best. The stage above comes from dated public records, not from the video.
From the video's description
The Synaptix Digital Surgery Platform is purpose-built to enhance the Symani Surgical System by supporting greater autonomy and workflow efficiency, improving the surgical experience for patients, surgeons, staff and hospitals. Learn more at: https://www.mmimicro.com/digital-surgery-synaptix/
Written by MMI - Medical Microinstruments, Inc. on YouTube.
More videos of Symani
Robotic-assisted Lymphovenous Bypass for Breast Cancer Related Lymphedema│ A Symani® Patient Story
Symani® Workflow | Robotic-assisted Procedure set-up with the Symani Surgical System
Symani® Surgical System Product Video | Robotic System Overview
MicroChats: Why Robotics in Microsurgery Matters
Robotic-Assisted Breast Reconstruction with Symani | A Connecting the Dots Series Story
Robotic-Assisted Breast Reconstruction Surgery | DIEP Surgery | A Symani® Patient Story